Avricore Health (AVCRF) Net Equity Issued and Repurchased (2009 - 2021)

Avricore Health (AVCRF) has reported Net Equity Issued and Repurchased for 9 consecutive years, with $1.9 million the latest figure, recorded in Q1 2021.

• In Q1 2021, Net Equity Issued and Repurchased changed N/A year-over-year to $1.9 million; the TTM figure through Dec 2021 stood at $1.9 million (changed N/A YoY), while the FY2021 annual figure was $1.9 million, up 310.51% from the prior year.
• Net Equity Issued and Repurchased climbed to $1.9 million in Q1 2021 per AVCRF's latest filing, from $259578.6 in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $1.9 million in Q1 2021 and bottomed at $37881.0 in Q4 2018.
• Historically, Net Equity Issued and Repurchased has averaged $524499.8 across 4 years, with a median of $240493.6 in 2019.
• On a YoY basis, Net Equity Issued and Repurchased climbed as much as 93.35% in 2018 and fell as far as 93.35% in 2018.
• Avricore Health's Net Equity Issued and Repurchased stood at $570048.4 in 2017, then plunged by 93.35% to $37881.0 in 2018, then soared by 585.25% to $259578.6 in 2019, then surged by 631.72% to $1.9 million in 2021.
• Business Quant data shows AVCRF's Net Equity Issued and Repurchased at $1.9 million in Q1 2021, $259578.6 in Q3 2019, and $221408.5 in Q1 2019.